Reviewing Myriad Genetics

Reviewing Myriad Genetics


Myriad Genetics and Cepheid are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitabiliy, institutional ownership and earnings. 95.8% of Cepheid shares are owned by institutional investors.



from Biotech News